Biochemics, Inc.
🇺🇸United States
Clinical Trials
2
Active:0
Completed:1
Trial Phases
2 Phases
Phase 1:1
Phase 2:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials
Phase 1
1 (50.0%)Phase 2
1 (50.0%)Safety and Efficacy Study of BC-DN-01 in Painful Diabetic Peripheral Neuropathy
Phase 1
Withdrawn
- Conditions
- Diabetic Neuropathy, Painful
- Interventions
- Drug: BC-DN-01 topically applied cream
- First Posted Date
- 2013-02-15
- Last Posted Date
- 2015-02-25
- Lead Sponsor
- BioChemics, Inc.
- Registration Number
- NCT01793350
- Locations
- 🇬🇧
Royal Hallamshire Hospital, Sheffield, South Yorkshire, United Kingdom
🇬🇧Ipswich Hospital, Ipswich, Suffolk, United Kingdom
🇬🇧Birmingham Heartlands Hospital, Birmingham, West Midlands, United Kingdom
Osteoarthritis Topical Treatment
- First Posted Date
- 2011-12-21
- Last Posted Date
- 2011-12-21
- Lead Sponsor
- BioChemics, Inc.
- Target Recruit Count
- 75
- Registration Number
- NCT01496326
- Locations
- 🇨🇭
Rheumaklinik und Institut für Physikalische Medizin Universitätsspital, Zürich, Switzerland
News
No news found